Moreover, data comparing IL‐5 levels in patients with T2 severe asthma and eosinophilic COPD are lacking; hence, it can be speculated that patients with COPD could have a lower baseline IL‐5 production compared to asthmatic patients. This evidence concerns the gene IL5 and asthma.